Total Payments
$65,634
2024 Payments
$38,817
Companies
43
Transactions
988
Medicare Patients
5,771
Medicare Billing
$870,201
Payment Breakdown by Category
Other$34,650 (52.8%)
Food & Beverage$18,441 (28.1%)
Education$8,631 (13.2%)
Travel$3,774 (5.8%)
Gifts$137.26 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,650 | 17 | 52.8% |
| Food and Beverage | $18,441 | 937 | 28.1% |
| Education | $8,631 | 17 | 13.2% |
| Travel and Lodging | $3,774 | 16 | 5.8% |
| Gift | $137.26 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $25,929 | 122 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $15,609 | 22 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $9,616 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,581 | 260 | $0 (2024) |
| Pulmonx Corporation | $1,968 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,862 | 137 | $0 (2024) |
| Mylan Specialty L.P. | $578.20 | 35 | $0 (2024) |
| Grifols USA, LLC | $549.69 | 36 | $0 (2024) |
| Insmed, Inc. | $514.80 | 29 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $472.79 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,817 | 198 | AstraZeneca Pharmaceuticals LP ($23,491) |
| 2023 | $4,122 | 171 | Pulmonx Corporation ($1,121) |
| 2022 | $1,904 | 115 | AstraZeneca Pharmaceuticals LP ($560.21) |
| 2021 | $2,514 | 75 | GlaxoSmithKline, LLC. ($754.26) |
| 2020 | $12,536 | 98 | Mallinckrodt Hospital Products Inc. ($9,417) |
| 2019 | $2,675 | 153 | GlaxoSmithKline, LLC. ($414.68) |
| 2018 | $1,412 | 96 | GlaxoSmithKline, LLC. ($429.88) |
| 2017 | $1,655 | 82 | GlaxoSmithKline, LLC. ($339.08) |
All Payment Transactions
988 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Immunology | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $88.71 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Pulmonology | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Immunology | ||||||
| 11/26/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 11/26/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
| 11/25/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,377 | 2,342 | $909,515 | $197,551 |
| 2022 | 22 | 1,576 | 2,590 | $986,510 | $221,709 |
| 2021 | 25 | 1,632 | 2,780 | $1.2M | $240,194 |
| 2020 | 21 | 1,186 | 2,289 | $1.0M | $210,747 |
Total Patients
5,771
Total Services
10,001
Medicare Billing
$870,201
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 361 | 817 | $354,390 | $85,296 | 24.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 210 | 641 | $153,885 | $44,026 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 130 | 130 | $73,265 | $18,210 | 24.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 114 | 120 | $75,680 | $17,938 | 23.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 75 | $27,490 | $7,595 | 27.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 75 | 78 | $16,545 | $3,773 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 44 | $13,600 | $3,006 | 22.1% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 75 | 78 | $12,330 | $3,001 | 24.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 76 | 79 | $10,985 | $2,764 | 25.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 36 | 36 | $3,960 | $2,589 | 65.4% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 13 | 13 | $61,500 | $2,178 | 3.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 15 | $6,585 | $1,701 | 25.8% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 17 | 17 | $22,590 | $1,425 | 6.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 37 | $3,860 | $1,257 | 32.6% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 11 | 11 | $44,940 | $833.99 | 1.9% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 22 | 22 | $19,780 | $718.50 | 3.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 31 | 32 | $1,280 | $328.96 | 25.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 30 | 31 | $1,085 | $264.30 | 24.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 23 | 23 | $4,215 | $248.40 | 5.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 29 | 30 | $900.00 | $228.90 | 25.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $650.00 | $170.30 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 392 | 806 | $350,280 | $87,126 | 24.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 217 | 683 | $160,025 | $41,225 | 25.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 144 | 155 | $100,490 | $25,705 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 128 | 128 | $72,200 | $17,850 | 24.7% |
About Dr. Nadeem Ali, M.D
Dr. Nadeem Ali, M.D is a Pulmonary Disease healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2012. The National Provider Identifier (NPI) number assigned to this provider is 1922374750.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nadeem Ali, M.D has received a total of $65,634 in payments from pharmaceutical and medical device companies, with $38,817 received in 2024. These payments were reported across 988 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,650).
As a Medicare-enrolled provider, Ali has provided services to 5,771 Medicare beneficiaries, totaling 10,001 services with total Medicare billing of $870,201. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Hackensack, NJ
- Active Since 03/27/2012
- Last Updated 03/09/2017
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1922374750
Products in Payments
- TEZSPIRE (Biological) $23,004
- Da Vinci Surgical System (Device) $15,609
- ACTHAR (Biological) $9,643
- NUCALA (Biological) $1,613
- TRELEGY ELLIPTA (Drug) $1,279
- FASENRA (Biological) $1,224
- OFEV (Drug) $1,065
- ZEPHYR ENDOBRONCHIAL VALVE (Device) $954.27
- DUPIXENT (Biological) $912.67
- BREZTRI (Drug) $882.26
- CHARTIS CATHETER (Device) $709.84
- Arikayce (Drug) $498.56
- SYMBICORT (Drug) $428.02
- YUPELRI (Drug) $423.57
- Prolastin-C Liquid (Biological) $418.41
- STIOLTO RESPIMAT (Drug) $341.77
- Xolair (Biological) $305.70
- ANORO (Drug) $291.28
- AERO Stent and Delivery System (Device) $254.02
- LONHALA MAGNAIR (Drug) $251.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Hackensack
Dr. Emanuele Santomauro, Md, MD
Pulmonary Disease — Payments: $383,229
Pulmonary Disease $383,229
Dr. David Orr, Do, DO
Pulmonary Disease — Payments: $14,176
Pulmonary Disease $14,176
Dr. John Villa, Do, DO
Pulmonary Disease — Payments: $14,032
Pulmonary Disease $14,032
Dr. Keith Rose, M.d, M.D
Pulmonary Disease — Payments: $12,026
Pulmonary Disease $12,026
Dr. Sean Sadikot, M.d, M.D
Pulmonary Disease — Payments: $6,912
Pulmonary Disease $6,912
Dr. Keith Brenner, M.d, M.D
Pulmonary Disease — Payments: $4,454
Pulmonary Disease $4,454